Investigation of lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) in the US.
Phase of Trial: Phase IV
Latest Information Update: 16 May 2016
At a glance
- Drugs Lomitapide (Primary)
- Indications Hyperlipoproteinaemia type II
- Focus Therapeutic Use
- 16 May 2016 Planned initiation date changed from 1 Oct 2015 to 1 Apr 2016, as per Aegerion media release.
- 04 May 2015 According to Aegerion media release, planned initiation date changed from 1 Jun 2014 to 1 Oct 2015.
- 14 Jan 2013 New trial record